Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

LifeMD (LFMDP) Equity Average (2016 - 2025)

Historic Equity Average for LifeMD (LFMDP) over the last 13 years, with Q3 2025 value amounting to $792799.0.

  • LifeMD's Equity Average rose 11704.27% to $792799.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $792799.0, marking a year-over-year increase of 11704.27%. This contributed to the annual value of -$2.4 million for FY2024, which is 3629.28% up from last year.
  • LifeMD's Equity Average amounted to $792799.0 in Q3 2025, which was up 11704.27% from -$2.1 million recorded in Q2 2025.
  • In the past 5 years, LifeMD's Equity Average ranged from a high of $17.4 million in Q1 2022 and a low of -$14.3 million during Q3 2023
  • Moreover, its 5-year median value for Equity Average was -$4.2 million (2023), whereas its average is -$3.2 million.
  • As far as peak fluctuations go, LifeMD's Equity Average surged by 75561.2% in 2022, and later tumbled by 268552.61% in 2023.
  • Over the past 5 years, LifeMD's Equity Average (Quarter) stood at $2.0 million in 2021, then plummeted by 424.38% to -$6.6 million in 2022, then skyrocketed by 35.93% to -$4.2 million in 2023, then plummeted by 67.18% to -$7.1 million in 2024, then surged by 111.18% to $792799.0 in 2025.
  • Its Equity Average was $792799.0 in Q3 2025, compared to -$2.1 million in Q2 2025 and -$5.7 million in Q1 2025.